Lathyrol inhibits the proliferation of Renca cells by altering expression of TGF-β/Smad pathway components and

Shengyou Song1, Yalin Song2

  • 1Department of Education, Shandong Provincial Hospital, Jinan, China.

Frontiers in Oncology
|October 24, 2025
PubMed
Abstract

Insights

Lathyrol inhibits renal cell carcinoma (RCC) proliferation by targeting the TGF-β/Smad pathway and arresting the cell cycle. This study demonstrates lathyrol

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Renal cell carcinoma (RCC) is a significant cause of cancer morbidity and mortality.
  • The transforming growth factor-beta (TGF-β)/Smad signaling pathway is implicated in RCC development and progression.

Purpose of the Study:

  • To investigate the anti-proliferative effects of lathyrol on Renca mouse RCC cells.
  • To elucidate the mechanism involving inhibition of the TGF-β/Smad pathway and cell cycle arrest.

Main Methods:

  • Utilized bioinformatics analysis, in vitro cell culture, and in vivo animal experiments.
  • Assessed the impact of lathyrol on RCC cell activity, gene and protein expression, and tumor growth.
  • Examined the expression of key proteins in the TGF-β/Smad pathway and cell cycle regulators.

Main Results:

  • Lathyrol demonstrated a dose-dependent inhibition of RCC cell proliferation.
  • In vitro, lathyrol modulated TGF-β1, Smad6, and other Smad proteins; in vivo, it suppressed TGF-β1, TGF-βR1, and Smad proteins while upregulating Smad6.
  • Lathyrol decreased expression of cyclins and CDKs, and increased expression of P16, P21, and P27, indicating cell cycle arrest.

Conclusions:

  • Lathyrol represses key TGF-β/Smad pathway proteins, hinders signal transduction, and induces cell cycle arrest in RCC cells.
  • Lathyrol effectively inhibits RCC cell proliferation, suggesting its potential as a therapeutic agent.
  • Further research is warranted to fully explore lathyrol's mechanism in RCC treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K